APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunomodulators

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Immunomodulators Market Analysis and Forecast 2026-2032

22 December 2025191 pages

Choose your research edition.

Industry ResearchImmunomodulators Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunomodulators Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Immunomodulators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunomodulators Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunomodulators Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Immunomodulators market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Immunomodulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Immunomodulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Immunomodulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Immunomodulators is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Immunomodulators include Abbott, Johnson & Johnson, Novartis AG, Merck & Co. Inc., Roche, Eli Lilly and Company, Biogen, Amgen Inc. and Bristol-Myers Squibb Company, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Immunomodulators, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Immunomodulators, also provides the sales of main regions and countries. Of the upcoming market potential for Immunomodulators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immunomodulators sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunomodulators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Immunomodulators sales, projected growth trends, production technology, application and end-user industry.

Immunomodulators Segment by Company

Abbott

Johnson & Johnson

Novartis AG

Merck & Co. Inc.

Roche

Eli Lilly and Company

Biogen

Amgen Inc.

Bristol-Myers Squibb Company

Immunomodulators Segment by Type

Immunosuppressant

Immunostimulants

Immunomodulators Segment by Application

HIV

Respiratory

Oncology

Others

Immunomodulators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunomodulators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunomodulators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunomodulators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Immunomodulators in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Immunomodulators manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunomodulators sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Immunomodulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Immunosuppressant Major Manufacturers Table 3. Immunostimulants Major Manufacturers Table 4. Global Immunomodulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. HIV Major Manufacturers Table 6. Respiratory Major Manufacturers Table 7. Oncology Major Manufacturers Table 8. Others Major Manufacturers Table 9. Immunomodulators Industry Trends Table 10. Immunomodulators Industry Drivers Table 11. Immunomodulators Industry Opportunities and Challenges Table 12. Immunomodulators Industry Restraints Table 13. Global Immunomodulators Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Immunomodulators Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Immunomodulators Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Immunomodulators Revenue Market Share by Region (2021-2026) Table 17. Global Immunomodulators Revenue Market Share by Region (2027-2032) Table 18. Global Immunomodulators Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Immunomodulators Sales by Region (2021-2026) & (k units) Table 20. Global Immunomodulators Sales by Region (2027-2032) & (k units) Table 21. Global Immunomodulators Sales Market Share by Region (2021-2026) Table 22. Global Immunomodulators Sales Market Share by Region (2027-2032) Table 23. Global Immunomodulators Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Immunomodulators Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Immunomodulators Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Immunomodulators Sales Market Share by Manufacturers (2021-2026) Table 27. Global Immunomodulators Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Immunomodulators Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Immunomodulators Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Immunomodulators Manufacturers, Product Type & Application Table 31. Global Immunomodulators Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Immunomodulators by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Immunomodulators Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Immunomodulators Revenue Market Share by Type (2021-2026) Table 38. Global Immunomodulators Revenue Market Share by Type (2027-2032) Table 39. Global Immunomodulators Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Immunomodulators Sales by Type (2021-2026) & (k units) Table 41. Global Immunomodulators Sales by Type (2027-2032) & (k units) Table 42. Global Immunomodulators Sales Market Share by Type (2021-2026) Table 43. Global Immunomodulators Sales Market Share by Type (2027-2032) Table 44. Global Immunomodulators Price by Type (2021-2026) & (US$/unit) Table 45. Global Immunomodulators Price by Type (2027-2032) & (US$/unit) Table 46. Global Immunomodulators Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Immunomodulators Revenue Market Share by Application (2021-2026) Table 50. Global Immunomodulators Revenue Market Share by Application (2027-2032) Table 51. Global Immunomodulators Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Immunomodulators Sales by Application (2021-2026) & (k units) Table 53. Global Immunomodulators Sales by Application (2027-2032) & (k units) Table 54. Global Immunomodulators Sales Market Share by Application (2021-2026) Table 55. Global Immunomodulators Sales Market Share by Application (2027-2032) Table 56. Global Immunomodulators Price by Application (2021-2026) & (US$/unit) Table 57. Global Immunomodulators Price by Application (2027-2032) & (US$/unit) Table 58. Abbott Company Information Table 59. Abbott Business Overview Table 60. Abbott Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Abbott Immunomodulators Product Portfolio Table 62. Abbott Recent Development Table 63. Johnson & Johnson Company Information Table 64. Johnson & Johnson Business Overview Table 65. Johnson & Johnson Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Johnson & Johnson Immunomodulators Product Portfolio Table 67. Johnson & Johnson Recent Development Table 68. Novartis AG Company Information Table 69. Novartis AG Business Overview Table 70. Novartis AG Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Novartis AG Immunomodulators Product Portfolio Table 72. Novartis AG Recent Development Table 73. Merck & Co. Inc. Company Information Table 74. Merck & Co. Inc. Business Overview Table 75. Merck & Co. Inc. Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Merck & Co. Inc. Immunomodulators Product Portfolio Table 77. Merck & Co. Inc. Recent Development Table 78. Roche Company Information Table 79. Roche Business Overview Table 80. Roche Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Roche Immunomodulators Product Portfolio Table 82. Roche Recent Development Table 83. Eli Lilly and Company Company Information Table 84. Eli Lilly and Company Business Overview Table 85. Eli Lilly and Company Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Eli Lilly and Company Immunomodulators Product Portfolio Table 87. Eli Lilly and Company Recent Development Table 88. Biogen Company Information Table 89. Biogen Business Overview Table 90. Biogen Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Biogen Immunomodulators Product Portfolio Table 92. Biogen Recent Development Table 93. Amgen Inc. Company Information Table 94. Amgen Inc. Business Overview Table 95. Amgen Inc. Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Amgen Inc. Immunomodulators Product Portfolio Table 97. Amgen Inc. Recent Development Table 98. Bristol-Myers Squibb Company Company Information Table 99. Bristol-Myers Squibb Company Business Overview Table 100. Bristol-Myers Squibb Company Immunomodulators Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Bristol-Myers Squibb Company Immunomodulators Product Portfolio Table 102. Bristol-Myers Squibb Company Recent Development Table 103. North America Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 104. North America Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 105. North America Immunomodulators Sales by Type (2021-2026) & (k units) Table 106. North America Immunomodulators Sales by Type (2027-2032) & (k units) Table 107. North America Immunomodulators Sales Price by Type (2021-2026) & (US$/unit) Table 108. North America Immunomodulators Sales Price by Type (2027-2032) & (US$/unit) Table 109. North America Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Immunomodulators Sales by Application (2021-2026) & (k units) Table 112. North America Immunomodulators Sales by Application (2027-2032) & (k units) Table 113. North America Immunomodulators Sales Price by Application (2021-2026) & (US$/unit) Table 114. North America Immunomodulators Sales Price by Application (2027-2032) & (US$/unit) Table 115. North America Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. North America Immunomodulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 117. North America Immunomodulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 118. North America Immunomodulators Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 119. North America Immunomodulators Sales by Country (2021-2026) & (k units) Table 120. North America Immunomodulators Sales by Country (2027-2032) & (k units) Table 121. North America Immunomodulators Sales Price by Country (2021-2026) & (US$/unit) Table 122. North America Immunomodulators Sales Price by Country (2027-2032) & (US$/unit) Table 123. United States Immunomodulators Revenue (2021-2032) & (US$ Million) Table 124. Canada Immunomodulators Revenue (2021-2032) & (US$ Million) Table 125. Mexico Immunomodulators Revenue (2021-2032) & (US$ Million) Table 126. Europe Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 127. Europe Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 128. Europe Immunomodulators Sales by Type (2021-2026) & (k units) Table 129. Europe Immunomodulators Sales by Type (2027-2032) & (k units) Table 130. Europe Immunomodulators Sales Price by Type (2021-2026) & (US$/unit) Table 131. Europe Immunomodulators Sales Price by Type (2027-2032) & (US$/unit) Table 132. Europe Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 133. Europe Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 134. Europe Immunomodulators Sales by Application (2021-2026) & (k units) Table 135. Europe Immunomodulators Sales by Application (2027-2032) & (k units) Table 136. Europe Immunomodulators Sales Price by Application (2021-2026) & (US$/unit) Table 137. Europe Immunomodulators Sales Price by Application (2027-2032) & (US$/unit) Table 138. Europe Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. Europe Immunomodulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 140. Europe Immunomodulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 141. Europe Immunomodulators Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 142. Europe Immunomodulators Sales by Country (2021-2026) & (k units) Table 143. Europe Immunomodulators Sales by Country (2027-2032) & (k units) Table 144. Europe Immunomodulators Sales Price by Country (2021-2026) & (US$/unit) Table 145. Europe Immunomodulators Sales Price by Country (2027-2032) & (US$/unit) Table 146. Germany Immunomodulators Revenue (2021-2032) & (US$ Million) Table 147. France Immunomodulators Revenue (2021-2032) & (US$ Million) Table 148. U.K. Immunomodulators Revenue (2021-2032) & (US$ Million) Table 149. Italy Immunomodulators Revenue (2021-2032) & (US$ Million) Table 150. Russia Immunomodulators Revenue (2021-2032) & (US$ Million) Table 151. Spain Immunomodulators Revenue (2021-2032) & (US$ Million) Table 152. Netherlands Immunomodulators Revenue (2021-2032) & (US$ Million) Table 153. Switzerland Immunomodulators Revenue (2021-2032) & (US$ Million) Table 154. Sweden Immunomodulators Revenue (2021-2032) & (US$ Million) Table 155. Poland Immunomodulators Revenue (2021-2032) & (US$ Million) Table 156. China Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 157. China Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 158. China Immunomodulators Sales by Type (2021-2026) & (k units) Table 159. China Immunomodulators Sales by Type (2027-2032) & (k units) Table 160. China Immunomodulators Sales Price by Type (2021-2026) & (US$/unit) Table 161. China Immunomodulators Sales Price by Type (2027-2032) & (US$/unit) Table 162. China Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 163. China Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 164. China Immunomodulators Sales by Application (2021-2026) & (k units) Table 165. China Immunomodulators Sales by Application (2027-2032) & (k units) Table 166. China Immunomodulators Sales Price by Application (2021-2026) & (US$/unit) Table 167. China Immunomodulators Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 169. Asia Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 170. Asia Immunomodulators Sales by Type (2021-2026) & (k units) Table 171. Asia Immunomodulators Sales by Type (2027-2032) & (k units) Table 172. Asia Immunomodulators Sales Price by Type (2021-2026) & (US$/unit) Table 173. Asia Immunomodulators Sales Price by Type (2027-2032) & (US$/unit) Table 174. Asia Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 175. Asia Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 176. Asia Immunomodulators Sales by Application (2021-2026) & (k units) Table 177. Asia Immunomodulators Sales by Application (2027-2032) & (k units) Table 178. Asia Immunomodulators Sales Price by Application (2021-2026) & (US$/unit) Table 179. Asia Immunomodulators Sales Price by Application (2027-2032) & (US$/unit) Table 180. Asia Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Asia Immunomodulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 182. Asia Immunomodulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 183. Asia Immunomodulators Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 184. Asia Immunomodulators Sales by Country (2021-2026) & (k units) Table 185. Asia Immunomodulators Sales by Country (2027-2032) & (k units) Table 186. Asia Immunomodulators Sales Price by Country (2021-2026) & (US$/unit) Table 187. Asia Immunomodulators Sales Price by Country (2027-2032) & (US$/unit) Table 188. Japan Immunomodulators Revenue (2021-2032) & (US$ Million) Table 189. South Korea Immunomodulators Revenue (2021-2032) & (US$ Million) Table 190. India Immunomodulators Revenue (2021-2032) & (US$ Million) Table 191. Australia Immunomodulators Revenue (2021-2032) & (US$ Million) Table 192. Taiwan Immunomodulators Revenue (2021-2032) & (US$ Million) Table 193. Southeast Asia Immunomodulators Revenue (2021-2032) & (US$ Million) Table 194. SAMEA Immunomodulators Revenue by Type (2021-2026) & (US$ Million) Table 195. SAMEA Immunomodulators Revenue by Type (2027-2032) & (US$ Million) Table 196. SAMEA Immunomodulators Sales by Type (2021-2026) & (k units) Table 197. SAMEA Immunomodulators Sales by Type (2027-2032) & (k units) Table 198. SAMEA Immunomodulators Sales Price by Type (2021-2026) & (US$/unit) Table 199. SAMEA Immunomodulators Sales Price by Type (2027-2032) & (US$/unit) Table 200. SAMEA Immunomodulators Revenue by Application (2021-2026) & (US$ Million) Table 201. SAMEA Immunomodulators Revenue by Application (2027-2032) & (US$ Million) Table 202. SAMEA Immunomodulators Sales by Application (2021-2026) & (k units) Table 203. SAMEA Immunomodulators Sales by Application (2027-2032) & (k units) Table 204. SAMEA Immunomodulators Sales Price by Application (2021-2026) & (US$/unit) Table 205. SAMEA Immunomodulators Sales Price by Application (2027-2032) & (US$/unit) Table 206. SAMEA Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. SAMEA Immunomodulators Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. SAMEA Immunomodulators Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. SAMEA Immunomodulators Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 210. SAMEA Immunomodulators Sales by Country (2021-2026) & (k units) Table 211. SAMEA Immunomodulators Sales by Country (2027-2032) & (k units) Table 212. SAMEA Immunomodulators Sales Price by Country (2021-2026) & (US$/unit) Table 213. SAMEA Immunomodulators Sales Price by Country (2027-2032) & (US$/unit) Table 214. Brazil Immunomodulators Revenue (2021-2032) & (US$ Million) Table 215. Argentina Immunomodulators Revenue (2021-2032) & (US$ Million) Table 216. Chile Immunomodulators Revenue (2021-2032) & (US$ Million) Table 217. Colombia Immunomodulators Revenue (2021-2032) & (US$ Million) Table 218. Peru Immunomodulators Revenue (2021-2032) & (US$ Million) Table 219. Saudi Arabia Immunomodulators Revenue (2021-2032) & (US$ Million) Table 220. Israel Immunomodulators Revenue (2021-2032) & (US$ Million) Table 221. UAE Immunomodulators Revenue (2021-2032) & (US$ Million) Table 222. Turkey Immunomodulators Revenue (2021-2032) & (US$ Million) Table 223. Iran Immunomodulators Revenue (2021-2032) & (US$ Million) Table 224. Egypt Immunomodulators Revenue (2021-2032) & (US$ Million) Table 225. Key Raw Materials Table 226. Raw Materials Key Suppliers Table 227. Immunomodulators Distributors List Table 228. Immunomodulators Customers List Table 229. Research Programs/Design for This Report Table 230. Authors List of This Report Table 231. Secondary Sources Table 232. Primary Sources List of Figures Figure 1. Immunomodulators Image Figure 2. Global Immunomodulators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunomodulators Market Size Share 2021 VS 2025 VS 2032 Figure 4. Immunosuppressant Image Figure 5. Immunostimulants Image Figure 6. Global Immunomodulators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Immunomodulators Market Size Share 2021 VS 2025 VS 2032 Figure 8. HIV Image Figure 9. Respiratory Image Figure 10. Oncology Image Figure 11. Others Image Figure 12. Global Immunomodulators Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Immunomodulators Revenue (2021-2032) & (US$ Million) Figure 14. Global Immunomodulators Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Immunomodulators Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Immunomodulators Revenue Market Share by Region (2021-2032) Figure 17. Global Immunomodulators Sales (2021-2032) & (k units) Figure 18. Global Immunomodulators Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Immunomodulators Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Immunomodulators Sales YoY (2021-2032) & (k units) Figure 21. Europe Immunomodulators Sales YoY (2021-2032) & (k units) Figure 22. China Immunomodulators Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Immunomodulators Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Immunomodulators Sales YoY (2021-2032) & (k units) Figure 25. Global Immunomodulators Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Immunomodulators Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Immunomodulators Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Immunomodulators Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Immunomodulators Revenue Market Share by Type (2021-2032) Figure 31. Global Immunomodulators Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Immunomodulators Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Immunomodulators Sales Market Share by Type (2021-2032) Figure 34. Global Immunomodulators Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Immunomodulators Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Immunomodulators Revenue Market Share by Application (2021-2032) Figure 37. Global Immunomodulators Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Immunomodulators Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Immunomodulators Sales Market Share by Application (2021-2032) Figure 40. North America Immunomodulators Revenue Share by Type (2021-2032) Figure 41. North America Immunomodulators Sales Share by Type (2021-2032) Figure 42. North America Immunomodulators Revenue Share by Application (2021-2032) Figure 43. North America Immunomodulators Sales Share by Application (2021-2032) Figure 44. North America Immunomodulators Revenue Share by Country (2021-2032) Figure 45. North America Immunomodulators Sales Share by Country (2021-2032) Figure 46. Europe Immunomodulators Revenue Share by Type (2021-2032) Figure 47. Europe Immunomodulators Sales Share by Type (2021-2032) Figure 48. Europe Immunomodulators Revenue Share by Application (2021-2032) Figure 49. Europe Immunomodulators Sales Share by Application (2021-2032) Figure 50. Europe Immunomodulators Revenue Share by Country (2021-2032) Figure 51. Europe Immunomodulators Sales Share by Country (2021-2032) Figure 52. China Immunomodulators Revenue Share by Type (2021-2032) Figure 53. China Immunomodulators Sales Share by Type (2021-2032) Figure 54. China Immunomodulators Revenue Share by Application (2021-2032) Figure 55. China Immunomodulators Sales Share by Application (2021-2032) Figure 56. Asia Immunomodulators Revenue Share by Type (2021-2032) Figure 57. Asia Immunomodulators Sales Share by Type (2021-2032) Figure 58. Asia Immunomodulators Revenue Share by Application (2021-2032) Figure 59. Asia Immunomodulators Sales Share by Application (2021-2032) Figure 60. Asia Immunomodulators Revenue Share by Country (2021-2032) Figure 61. Asia Immunomodulators Sales Share by Country (2021-2032) Figure 62. SAMEA Immunomodulators Revenue Share by Type (2021-2032) Figure 63. SAMEA Immunomodulators Sales Share by Type (2021-2032) Figure 64. SAMEA Immunomodulators Revenue Share by Application (2021-2032) Figure 65. SAMEA Immunomodulators Sales Share by Application (2021-2032) Figure 66. SAMEA Immunomodulators Revenue Share by Country (2021-2032) Figure 67. SAMEA Immunomodulators Sales Share by Country (2021-2032) Figure 68. Immunomodulators Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Immunomodulators Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Immunosuppressant
  • Immunostimulants
Applications
  • HIV
  • Respiratory
  • Oncology
  • Others
Companies covered
  • Abbott
  • Johnson & Johnson
  • Novartis AG
  • Merck & Co. Inc.
  • Roche
  • Eli Lilly and Company
  • Biogen
  • Amgen Inc.
  • Bristol-Myers Squibb Company

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Immunomodulators Market by Type
  3. 1.2.1 Global Immunomodulators Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Immunosuppressant
  5. 1.2.3 Immunostimulants
  6. 1.3 Immunomodulators Market by Application
  7. 1.3.1 Global Immunomodulators Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 HIV
  9. 1.3.3 Respiratory
  10. 1.3.4 Oncology
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Immunomodulators Market Dynamics
  1. 2.1 Immunomodulators Industry Trends
  2. 2.2 Immunomodulators Industry Drivers
  3. 2.3 Immunomodulators Industry Opportunities and Challenges
  4. 2.4 Immunomodulators Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Immunomodulators Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Immunomodulators Revenue by Region
  3. 3.2.1 Global Immunomodulators Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Immunomodulators Revenue by Region (2021-2026)
  5. 3.2.3 Global Immunomodulators Revenue by Region (2027-2032)
  6. 3.2.4 Global Immunomodulators Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Immunomodulators Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Immunomodulators Sales by Region
  9. 3.4.1 Global Immunomodulators Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Immunomodulators Sales by Region (2021-2026)
  11. 3.4.3 Global Immunomodulators Sales by Region (2027-2032)
  12. 3.4.4 Global Immunomodulators Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Immunomodulators Revenue by Manufacturers
  2. 4.1.1 Global Immunomodulators Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Immunomodulators Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Immunomodulators Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Immunomodulators Sales by Manufacturers
  6. 4.2.1 Global Immunomodulators Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Immunomodulators Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Immunomodulators Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Immunomodulators Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Immunomodulators Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Immunomodulators Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Immunomodulators Manufacturers, Product Type & Application
  13. 4.7 Global Immunomodulators Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Immunomodulators Market CR5 and HHI
  16. 4.8.2 2025 Immunomodulators Tier 1, Tier 2, and Tier 3
5 Immunomodulators Market by Type
  1. 5.1 Global Immunomodulators Revenue by Type
  2. 5.1.1 Global Immunomodulators Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Immunomodulators Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Immunomodulators Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Immunomodulators Sales by Type
  6. 5.2.1 Global Immunomodulators Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunomodulators Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Immunomodulators Sales Market Share by Type (2021-2032)
  9. 5.3 Global Immunomodulators Price by Type
6 Immunomodulators Market by Application
  1. 6.1 Global Immunomodulators Revenue by Application
  2. 6.1.1 Global Immunomodulators Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Immunomodulators Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Immunomodulators Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Immunomodulators Sales by Application
  6. 6.2.1 Global Immunomodulators Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Immunomodulators Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Immunomodulators Sales Market Share by Application (2021-2032)
  9. 6.3 Global Immunomodulators Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Immunomodulators Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Immunomodulators Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Novartis AG
  14. 7.3.1 Novartis AG Company Information
  15. 7.3.2 Novartis AG Business Overview
  16. 7.3.3 Novartis AG Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis AG Immunomodulators Product Portfolio
  18. 7.3.5 Novartis AG Recent Developments
  19. 7.4 Merck & Co. Inc.
  20. 7.4.1 Merck & Co. Inc. Company Information
  21. 7.4.2 Merck & Co. Inc. Business Overview
  22. 7.4.3 Merck & Co. Inc. Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck & Co. Inc. Immunomodulators Product Portfolio
  24. 7.4.5 Merck & Co. Inc. Recent Developments
  25. 7.5 Roche
  26. 7.5.1 Roche Company Information
  27. 7.5.2 Roche Business Overview
  28. 7.5.3 Roche Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Roche Immunomodulators Product Portfolio
  30. 7.5.5 Roche Recent Developments
  31. 7.6 Eli Lilly and Company
  32. 7.6.1 Eli Lilly and Company Company Information
  33. 7.6.2 Eli Lilly and Company Business Overview
  34. 7.6.3 Eli Lilly and Company Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly and Company Immunomodulators Product Portfolio
  36. 7.6.5 Eli Lilly and Company Recent Developments
  37. 7.7 Biogen
  38. 7.7.1 Biogen Company Information
  39. 7.7.2 Biogen Business Overview
  40. 7.7.3 Biogen Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Biogen Immunomodulators Product Portfolio
  42. 7.7.5 Biogen Recent Developments
  43. 7.8 Amgen Inc.
  44. 7.8.1 Amgen Inc. Company Information
  45. 7.8.2 Amgen Inc. Business Overview
  46. 7.8.3 Amgen Inc. Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Amgen Inc. Immunomodulators Product Portfolio
  48. 7.8.5 Amgen Inc. Recent Developments
  49. 7.9 Bristol-Myers Squibb Company
  50. 7.9.1 Bristol-Myers Squibb Company Company Information
  51. 7.9.2 Bristol-Myers Squibb Company Business Overview
  52. 7.9.3 Bristol-Myers Squibb Company Immunomodulators Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bristol-Myers Squibb Company Immunomodulators Product Portfolio
  54. 7.9.5 Bristol-Myers Squibb Company Recent Developments
8 North America
  1. 8.1 North America Immunomodulators Market Size by Type
  2. 8.1.1 North America Immunomodulators Revenue by Type (2021-2032)
  3. 8.1.2 North America Immunomodulators Sales by Type (2021-2032)
  4. 8.1.3 North America Immunomodulators Price by Type (2021-2032)
  5. 8.2 North America Immunomodulators Market Size by Application
  6. 8.2.1 North America Immunomodulators Revenue by Application (2021-2032)
  7. 8.2.2 North America Immunomodulators Sales by Application (2021-2032)
  8. 8.2.3 North America Immunomodulators Price by Application (2021-2032)
  9. 8.3 North America Immunomodulators Market Size by Country
  10. 8.3.1 North America Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Immunomodulators Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Immunomodulators Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Immunomodulators Market Size by Type
  2. 9.1.1 Europe Immunomodulators Revenue by Type (2021-2032)
  3. 9.1.2 Europe Immunomodulators Sales by Type (2021-2032)
  4. 9.1.3 Europe Immunomodulators Price by Type (2021-2032)
  5. 9.2 Europe Immunomodulators Market Size by Application
  6. 9.2.1 Europe Immunomodulators Revenue by Application (2021-2032)
  7. 9.2.2 Europe Immunomodulators Sales by Application (2021-2032)
  8. 9.2.3 Europe Immunomodulators Price by Application (2021-2032)
  9. 9.3 Europe Immunomodulators Market Size by Country
  10. 9.3.1 Europe Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Immunomodulators Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Immunomodulators Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Immunomodulators Market Size by Type
  2. 10.1.1 China Immunomodulators Revenue by Type (2021-2032)
  3. 10.1.2 China Immunomodulators Sales by Type (2021-2032)
  4. 10.1.3 China Immunomodulators Price by Type (2021-2032)
  5. 10.2 China Immunomodulators Market Size by Application
  6. 10.2.1 China Immunomodulators Revenue by Application (2021-2032)
  7. 10.2.2 China Immunomodulators Sales by Application (2021-2032)
  8. 10.2.3 China Immunomodulators Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Immunomodulators Market Size by Type
  2. 11.1.1 Asia Immunomodulators Revenue by Type (2021-2032)
  3. 11.1.2 Asia Immunomodulators Sales by Type (2021-2032)
  4. 11.1.3 Asia Immunomodulators Price by Type (2021-2032)
  5. 11.2 Asia Immunomodulators Market Size by Application
  6. 11.2.1 Asia Immunomodulators Revenue by Application (2021-2032)
  7. 11.2.2 Asia Immunomodulators Sales by Application (2021-2032)
  8. 11.2.3 Asia Immunomodulators Price by Application (2021-2032)
  9. 11.3 Asia Immunomodulators Market Size by Country
  10. 11.3.1 Asia Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Immunomodulators Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Immunomodulators Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Immunomodulators Market Size by Type
  2. 12.1.1 SAMEA Immunomodulators Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Immunomodulators Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Immunomodulators Price by Type (2021-2032)
  5. 12.2 SAMEA Immunomodulators Market Size by Application
  6. 12.2.1 SAMEA Immunomodulators Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Immunomodulators Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Immunomodulators Price by Application (2021-2032)
  9. 12.3 SAMEA Immunomodulators Market Size by Country
  10. 12.3.1 SAMEA Immunomodulators Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Immunomodulators Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Immunomodulators Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Immunomodulators Value Chain Analysis
  2. 13.1.1 Immunomodulators Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Immunomodulators Production Mode & Process
  6. 13.2 Immunomodulators Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Immunomodulators Distributors
  9. 13.2.3 Immunomodulators Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst